Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.
- DOI
- 10.1002/1545-5017.70513
- Published
- 2026 Sep
- Container
- Pediatric blood & cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1545-5017.70513,
title = {Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.},
author = {Poulsen C and Sandahl KJ and Karlsson L and Abrahamsson J and Arad-Cohen N and Cheuk D and De Moerloose B and Fogelstrand L and Navarro JMF and Goemans BF and Jahnukainen K and Kaspers G and Kovalova Z and Munthe-Kaas MC and Norén-Nyström U and Palle J and Pasauliene R and Pronk CJ and Saks K and Tierens A and Hasle H and Juul-Dam KL},
year = {2026},
journal = {Pediatric blood \& cancer},
doi = {10.1002/1545-5017.70513},
url = {https://doi.org/10.1002/1545-5017.70513}
}RIS
TY - JOUR TI - Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse. AU - Poulsen C AU - Sandahl KJ AU - Karlsson L AU - Abrahamsson J AU - Arad-Cohen N AU - Cheuk D AU - De Moerloose B AU - Fogelstrand L AU - Navarro JMF AU - Goemans BF AU - Jahnukainen K AU - Kaspers G AU - Kovalova Z AU - Munthe-Kaas MC AU - Norén-Nyström U AU - Palle J AU - Pasauliene R AU - Pronk CJ AU - Saks K AU - Tierens A AU - Hasle H AU - Juul-Dam KL PY - 2026 JO - Pediatric blood & cancer DO - 10.1002/1545-5017.70513 UR - https://doi.org/10.1002/1545-5017.70513 ER -
APA
C, P., KJ, S., L, K., J, A., N, A., D, C., B, D. M., L, F., JMF, N., BF, G., K, J., G, K., Z, K., MC, M., U, N., J, P., R, P., CJ, P., K, S., A, T., H, H., & KL, J. (2026). Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70513
Source records
- pubmed · retrieved 2026-09-26T10:53:22.518Z